Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND)

Clinical trial NCT07360977 · RECRUITING

Trial details

NCT number: NCT07360977
Sponsor: IRCCS Centro Neurolesi Bonino Pulejo
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

PARKINSON DISEASE (Disorder)Multiple Sclerosis (MS) - Relapsing-remitting Pediatric Patients Affected by Neuromuscolar and Degenerative Diseases

Start date: 2026-01-01
Primary completion: 2026-05-19
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.